Skip to main navigation Skip to main content
  • KAPS
  • E-Submission

APS : Advances in Pediatric Surgery

OPEN ACCESS
Search
Advanced Search
ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS

Articles

Page Path

Original Article

The Treatment Experience of Lymphatic Malformations in Pediatric Patients

Jae Ha Park, So Hyun Namorcid
Journal of the Korean Association of Pediatric Surgeons 2018;24(1):14-19.
Published online: June 30, 2018

Department of Surgery, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea.

Correspondence: So Hyun Nam, Department of Surgery, Dong-A University Medical Center, Dong-A University College of Medicine, 26 Daesingongwon-ro, Seo-gu, Busan 49201, Korea. Tel: +82-51-240-5146, Fax: +82-51-247-9316, namsh@dau.ac.kr
• Received: April 12, 2018   • Revised: June 1, 2018   • Accepted: June 7, 2018

Copyright © 2018 Korean Association of Pediatric Surgeons

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 0 Views
  • 0 Download
prev next

Full Article

Download PDF Download PDF
  • Purpose
    The management of lymphatic malformation (LM) in pediatric patients is challenging. Complete excision of LM is difficult to achieve in some cases. We reviewed our experience how to manage LM.
  • Methods
    We retrospectively reviewed the patients who were treated for LM between 2010 and 2017. Medical records were reviewed about age of diagnosis, age of treatment age, gender, symptom, location of tumor, treatment modality, response and complication.
  • Results
    Sixty-three patients (39 boys and 24 girls) were included. Mean age at diagnosis was 14.5±28.0 months (range, neonate-10 years). The involved lesion were head and neck in 27 patients (42.9%), abdominal cavity in 7 patients (11.1%), chest wall and abdominal wall in 11 patients (17.5%), buttock in 7 patients (11.1%), and extremities in 11 patients (17.5%). The treatment options were including surgical resection in 32 patients, sclerotherapy in 7 patients, surgical resection combined sclerotherapy in 19 patients, and close observation in 5 patients. We achieved complete remission in 39 patients. Fourteen patients showed partial remission and 6 showed recurrences.
  • Conclusion
    Despite surgical difficulty, meticulous excision with supportive treatment, and adjuvant sclerotherapy could get a favorable outcome without fatal complication. Decision should be based on surgeon's experience, location of LM, related symptoms, and consultation with patient's parents.
  • Keywords: Lymphangioma; Sclerotherapy; Picibanil

No potential conflict of interest relevant to this article was reported.

  • 1. Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM. 25 years' experience with lymphangiomas in children. J Pediatr Surg 1999;34:1164-1168.
  • 2. Oshikiri T, Morikawa T, Jinushi E, Kawakami Y, Katoh H. Five cases of the lymphangioma of the mediastinum in adult. Ann Thorac Cardiovasc Surg 2001;7:103-105.
  • 3. Elluru RG, Balakrishnan K, Padua HM. Lymphatic malformations: diagnosis and management. Semin Pediatr Surg 2014;23:178-185.
  • 4. Giguère CM, Bauman NM, Smith RJ. New treatment options for lymphangioma in infants and children. Ann Otol Rhinol Laryngol 2002;111:1066-1075.
  • 5. Sanlialp I, Karnak I, Tanyel FC, Senocak ME, Büyükpamukçu N. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol 2003;67:795-800.
  • 6. Lee JH, Choi SO, Park WH. Abdominal cystic lymphangioma. J Korean Assoc Pediatr Surg 2006;12:232-237.
  • 7. Zadvinskis DP, Benson MT, Kerr HH, Mancuso AA, Cacciarelli AA, Madrazo BL, et al. Congenital malformations of the cervicothoracic lymphatic system: embryology and pathogenesis. Radiographics 1992;12:1175-1189.
  • 8. Orvidas LJ, Kasperbauer JL. Pediatric lymphangiomas of the head and neck. Ann Otol Rhinol Laryngol 2000;109:411-421.
  • 9. Emery PJ, Bailey CM, Evans JN. Cystic hygroma of the head and neck. A review of 37 cases. J Laryngol Otol 1984;98:613-619.
  • 10. Brown RL, Azizkhan RG. Pediatric head and neck lesions. Pediatr Clin North Am 1998;45:889-905.
  • 11. Rostom AY. Treatment of thoracic lymphangiomatosis. Arch Dis Child 2000;83:138-139.
  • 12. BILL AH Jr, Sumner DS. A unified concept of lymphangioma and cystic hygroma. Surg Gynecol Obstet 1965;120:79-86.
  • 13. Hancock BJ, St-Vil D, Luks FI, Di Lorenzo M, Blanchard H. Complications of lymphangiomas in children. J Pediatr Surg 1992;27:220-224 discussion 224-6.
  • 14. Kim KH, Kim HH, Lee SK, Seo JM, Chang WY, Lee BB. OK-432 Intralesional injection therapy for lymphangioma in children. J Korean Assoc Pediatr Surg 2001;7:142-146.
  • 15. Kittredge RD, Finby N. The many facets of lymphangioma. Am J Roentgenol Radium Ther Nucl Med 1965;95:56-66.
  • 16. Okazaki T, Iwatani S, Yanai T, Kobayashi H, Kato Y, Marusasa T, et al. Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg 2007;42:386-389.
  • 17. Kang KS, Jung PM. Clinical manifestation and treatment of lymphangioma in children: a review of 117 cases. J Korean Assoc Pediatr Surg 2002;8:95-100.
  • 18. Pui MH, Li ZP, Chen W, Chen JH. Lymphangioma: imaging diagnosis. Australas Radiol 1997;41:324-328.
  • 19. Schmidt B, Schimpl G, Höllwarth ME. OK-432 therapy of lymphangiomas in children. Eur J Pediatr 1996;155:649-652.
  • 20. Mikhail M, Kennedy R, Cramer B, Smith T. Sclerosing of recurrent lymphangioma using OK-432. J Pediatr Surg 1995;30:1159-1160.
  • 21. Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N. OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg 1996;31:477-480.
  • 22. Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 1994;29:784-785.
  • 23. Hwang D, Lee S, Lim SY, Lee SK, Seo JM. Surgical treatment of difficult cervicofacial lymphangioma in children. J Korean Assoc Pediatr Surg 2015;21:17-23.
Table 1

Demographic Findings

Values are presented as ratio, mean±SD, or n only.

jkaps-24-14-i001.jpg
Table 2

Treatment Modality & Response

Sclero., sclerotherapy; Op., operation; (s), single; (m), multiple.

jkaps-24-14-i002.jpg
Table 3

Treatment Response according to Size and Type of Cyst

jkaps-24-14-i003.jpg

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

The Treatment Experience of Lymphatic Malformations in Pediatric Patients
J Korean Assoc Pediatr Surg. 2018;24(1):14-19.   Published online June 30, 2018
DOI: https://doi.org/10.13029/jkaps.2018.24.1.14
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
Format:
Include:
The Treatment Experience of Lymphatic Malformations in Pediatric Patients
J Korean Assoc Pediatr Surg. 2018;24(1):14-19.   Published online June 30, 2018
DOI: https://doi.org/10.13029/jkaps.2018.24.1.14
Close
The Treatment Experience of Lymphatic Malformations in Pediatric Patients
The Treatment Experience of Lymphatic Malformations in Pediatric Patients

Demographic Findings

Values are presented as ratio, mean±SD, or n only.

Treatment Modality & Response

Sclero., sclerotherapy; Op., operation; (s), single; (m), multiple.

Treatment Response according to Size and Type of Cyst

Table 1 Demographic Findings

Values are presented as ratio, mean±SD, or n only.

Table 2 Treatment Modality & Response

Sclero., sclerotherapy; Op., operation; (s), single; (m), multiple.

Table 3 Treatment Response according to Size and Type of Cyst

Table 1

Table 2

Table 3

APS : Advances in Pediatric Surgery

ABOUT

BROWSE ARTICLES

EDITORIAL POLICY

FOR CONTRIBUTORS

© The Korean Association of Pediatric Surgeons.